Skip to main content
Equibles
TFX logo

TFX · Teleflex Inc

Track TFX — free

Use TFX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$138.36 -1.60 (-1.14%) At close · Sep 4
S&P 600 member Russell 1000 member Rebalance outlook locked
Market Cap
$5.86B
Shares
42.37M

TFX metrics

91 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$138.36
Market cap
$5.86B

Price action

19 metrics
Price change (1W)
-0.9%
Price change (30D)
+4.0%
Price change (3M)
+6.6%
Price change (6M)
+22.1%
Price change (YTD)
+13.4%
Price change (1Y)
+7.2%
Trailing year
Price change (5Y)
-65.3%
52-week high
$142.05
52-week low
$100.34
Change from 52-week high
-2.6%
Change from 52-week low
+37.9%
Annualized volatility
40.2%
Beta
0.8
RSI (14D)
52.1
Price vs SMA 50
+2.4%
Price vs SMA 200
+12.4%
Avg volume (3M)
528,070
Relative volume
0.9
Average dollar volume
$70.90M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
42.37M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
3.7×
reciprocal yield 26.9%
EV / EBITDA
33.5×
reciprocal yield 3.0%
EV / EBIT
188.3×
reciprocal yield 0.5%
P / sales
2.6×
reciprocal yield 38.5%
P / book
2.0
reciprocal yield 49.5%
FCF yield
2.9%
TTM · current market cap
Buyback yield
4.3%
P / FCF
34.8
reciprocal yield 2.9%
P / operating cash flow
24.0
reciprocal yield 4.2%
Earnings yield
-17.6%

Historical valuation

8 metrics
P / E historical average (3Y)
32.4×
reciprocal yield 3.1%
P / E historical average (5Y)
36.9×
reciprocal yield 2.7%
EV / revenue historical average (3Y)
3.4×
reciprocal yield 29.1%
EV / revenue historical average (5Y)
4.1×
reciprocal yield 24.4%
EV / EBIT historical average (3Y)
57.1×
reciprocal yield 1.8%
EV / EBIT historical average (5Y)
42.8×
reciprocal yield 2.3%
EV / EBITDA historical average (3Y)
46.0×
reciprocal yield 2.2%
EV / EBITDA historical average (5Y)
46.0×
reciprocal yield 2.2%

Dividends & buybacks

7 metrics
Dividend yield
1.0%
Trailing 12 months
Payout ratio
—
Shareholder yield
5.3%
Dividend / share (TTM)
$1.36
Dividend growth YoY
+0.0%
Dividend growth streak
—
Last ex-dividend
2026-08-14

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
54.9%
Operating margin
2.0%
Trailing 12 months
Net margin
-45.8%
Gross profit (TTM)
$1.24B
Operating profit (TTM)
$44.44M
Net income (TTM)
−$1.03B
Trailing 12 months
Diluted EPS (TTM)
$-23.29
FCF margin
7.5%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+28.9%
Year over year
Net income growth YoY
-18.7%
Revenue (TTM)
$2.25B
Trailing 12 months
EPS growth YoY
-17.7%
Shares change YoY
-1.5%
Year over year · fewer shares
Revenue CAGR (3Y)
-10.6%
Revenue CAGR (5Y)
-4.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-82.4%
FCF CAGR (5Y)
-66.6%

Quality

14 metrics
Return on equity
-35.5%
Return on assets
-15.2%
Debt / equity
1.0
Current ratio
2.6
EBITDA (TTM)
$250.24M
Free cash flow (TTM)
$168.40M
Quick ratio
2.1
Interest coverage
0.4
Net debt / EBITDA
10.0
Return on invested capital
—
Trailing 12 months
Net cash
−$2.51B
Latest balance sheet
Cash & equivalents
$300.16M
Total assets
$6.79B
Total debt
$2.81B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$244.54M
Capital expenditures (TTM)
$76.14M
R&D (TTM)
$182.51M
SG&A (TTM)
$869.28M
Stock compensation (TTM)
$25.59M
R&D / revenue
8.1%
Stock compensation / revenue
1.1%

Ownership (13F)

3 metrics
13F filers
384
13F filer change QoQ
+16
Institutional ownership
113.3%

Short interest

3 metrics
Short interest
11.4%
Latest settlement · 6.4 days to cover
Days to cover
6.4d
Short-squeeze score
74 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 96943 CUSIP 879369106 13F (30d) 219 filings 218 filers Visit website Investor relations